S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Laser breakthrough could send stock soaring 2,467% (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
Laser breakthrough could send stock soaring 2,467% (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Laser breakthrough could send stock soaring 2,467% (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
North Korea notifies neighboring Japan it plans to launch satellite in coming days
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Laser breakthrough could send stock soaring 2,467% (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
Laser breakthrough could send stock soaring 2,467% (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Laser breakthrough could send stock soaring 2,467% (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
North Korea notifies neighboring Japan it plans to launch satellite in coming days
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Laser breakthrough could send stock soaring 2,467% (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
Laser breakthrough could send stock soaring 2,467% (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Laser breakthrough could send stock soaring 2,467% (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
North Korea notifies neighboring Japan it plans to launch satellite in coming days
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Laser breakthrough could send stock soaring 2,467% (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
Laser breakthrough could send stock soaring 2,467% (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Laser breakthrough could send stock soaring 2,467% (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Positive News SentimentPositive News
NASDAQ:CVRX

CVRx (CVRX) Price Target & Analyst Ratings

$13.25
+0.02 (+0.15%)
(As of 05/26/2023 04:00 PM ET)
Compare
Today's Range
$12.97
▼
$13.52
50-Day Range
$8.57
▼
$13.94
52-Week Range
$5.23
▼
$19.94
Volume
71,100 shs
Average Volume
258,721 shs
Market Capitalization
$274.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.80
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

CVRx Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 5 Analyst Ratings

Consensus Analyst Price Target

$18.80
41.89% Upside
High Prediction$23.00
Average Prediction$18.80
Low Prediction$15.00
TypeCurrent
5/29/22 to 5/29/23		1 Month Ago
4/29/22 to 4/29/23		3 Months Ago
2/28/22 to 2/28/23		1 Year Ago
5/29/21 to 5/29/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
3 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$18.80$19.20$19.20$20.84
Predicted Upside41.89% Upside34.87% Upside34.87% Upside18.03% Upside
Get CVRx Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter.


CVRX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CVRX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CVRx Stock vs. The Competition

TypeCVRxMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.66
2.48
Consensus RatingBuyBuyHold
Predicted Upside41.89% Upside1,318.29% Upside196.76% Upside
News Sentiment RatingVery Positive News
Positive News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/3/2023Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$15.00 ➝ $18.00+41.40%
2/10/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOverweight$18.50 ➝ $20.00+14.61%
2/7/2023Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy$22.00 ➝ $23.00+27.78%
1/27/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOverweight$17.00 ➝ $18.00+25.26%
7/18/2022Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageBuy$15.00+121.24%
(Data available from 5/29/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CVRX Price Target - Frequently Asked Questions

What is CVRx's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for CVRx stock is Buy based on the current 5 buy ratings for CVRX. The average twelve-month price prediction for CVRx is $18.80 with a high price target of $23.00 and a low price target of $15.00. Learn more on CVRX's analyst rating history.

Do Wall Street analysts like CVRx more than its competitors?

Analysts like CVRx more than other Medical companies. The consensus rating score for CVRx is 3.00 while the average consensus rating score for medical companies is 2.66. Learn more on how CVRX compares to other companies.

Does CVRx's stock price have much upside?

According to analysts, CVRx's stock has a predicted upside of 33.80% based on their 12-month price targets.

What analysts cover CVRx?

CVRx has been rated by Lake Street Capital in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:CVRX) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -